Skip to content

Clinical trials

Cognitive Dysfunction trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cognitive Dysfunction Country / region: Russia Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20132
20143
20161
20172
20182
20194
20201
20211
20221
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed14
Active, not recruiting2
Recruiting2
Terminated2
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.3
Materia Medica Holding2
Pharmasoft2
AO GENERIUM1
Eisai Co., Ltd.1
Eisai Inc.1
Federal Research Institute of Pediatric Hematology, Oncology and Immunology1
Federal Research and Clinical Centre of Intensive Care Medicine and Rehabilitology1
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health1
I.M. Sechenov First Moscow State Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cognitive Dysfunction21
Alzheimer Disease6
Dementia5
Mental Disorders4
Nervous System Diseases4
Psychomotor Agitation3
Ischemic Stroke2
Neurobehavioral Manifestations2
Sleep Wake Disorders2
Asthenia1

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.